Long-Term Tolerability and Safety of AAV5-Id3 Gene Therapy to Eyes

AAV5-Id3基因疗法治疗眼部疾病的长期耐受性和安全性

阅读:2

Abstract

PURPOSE: The inhibitor of differentiation 3 gene therapy via adeno-associated virus 5 (AAV5-Id3) effectively abrogated corneal fibrosis in vivo. This study examined the long-term tolerability and safety of AAV5-Id3 gene therapy for eyes in vivo using a rabbit model. METHODS: Eighteen New Zealand White rabbits, segregated into three groups (naive, AAV5-naked, and AAV5-Id3; n = 6/group), were used. The clinical eye examinations with slit-lamp and multimodal corneal imaging were performed in live rabbits periodically to record the status of ocular and corneal health for up to 7 months. Thereafter, humane euthanasia was performed, and cellular and molecular changes in corneas were studied employing histopathologic, immunofluorescence, and quantitative reverse transcription polymerase chain reaction (RT-PCR) techniques. RESULTS: Periodic masked eye examinations with slit-lamp, Spectralis, HRT3-RCM, and specular ophthalmic microscopes found no significant differences in the corneas of naive, AAV5-naked, and AAV5-Id3 groups. Modified McDonald-Shadduck scores revealed no signs of blepharospasm, chemosis, abnormal discharge, epiphora, erythema, or epithelial abrasion in three groups. Pachymetry, tonometry, and fluorescein testing detected no alterations in corneal thickness, intraocular pressure, and tear volume in eyes of the three groups. Histopathologic studies revealed corneal architecture, cellular organization, cellular morphology, and collagen levels similar in eyes of the three groups. Quantitative RT-PCR analysis did not find changes in nuclear factor κB, tumor necrosis factor α, α-smooth muscle actin, fibronectin, vascular endothelial growth factor, and pigment epithelium-derived factor messenger RNA levels in three test groups. At 7 months, AAV5-Id3 corneas had 2.73 × 102 ± 0.34 delivered-Id3 gene copies. CONCLUSIONS: Targeted topical AAV5-Id3 gene therapy is tolerable, safe, and nontoxic to the eyes in vivo. TRANSLATIONAL RELEVANCE: Topical AAV5-Id3 gene therapy treats corneal fibrosis without significant side effects in vivo.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。